MEGAN HOLLEMAN: Open Payments
NPI 1659076859 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,386 in 18 payments from 9 companies in 2025. Trend: 2023 $787 · 2024 $2,220 · 2025 $1,386
Food & beverage: $1,281Education: $106
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $391 |
| ABBVIE INC. | 3 | $274 |
| GENZYME CORPORATION | 2 | $153 |
| UCB, Inc. | 1 | $146 |
| Regeneron Healthcare Solutions, Inc. | 3 | $141 |
| Amgen Inc. | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 1 | $51 |
| Organon LLC | 2 | $6 |
Products named: DUPIXENT, NEMLUVIO, SKYRIZI, Bimzelx, Otezla, RINVOQ.
Industry payments across CO — which companies pay providers there.
